Racial/Ethnic Disparities Across Indicators of Cigarette Smoking in the Era of Increased Tobacco Control, 1992-2019.


Journal

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco
ISSN: 1469-994X
Titre abrégé: Nicotine Tob Res
Pays: England
ID NLM: 9815751

Informations de publication

Date de publication:
24 05 2021
Historique:
received: 10 03 2020
accepted: 11 11 2020
pubmed: 17 11 2020
medline: 26 10 2021
entrez: 16 11 2020
Statut: ppublish

Résumé

This study compared tobacco use and cessation for African Americans (AA), Asians/Pacific Islanders (API), Hispanics/Latinos (H/L), American Indian/Alaskan Natives (AI/AN), and non-Hispanic Whites (NHW) in the United States to California (CA), the state with the longest continually funded tobacco control program. The purpose of this study was to identify tobacco use disparities across racial/ethnic groups across time. Cigarette use prevalence (uptake and current use), consumption (mean number of cigarettes smoked per day [CPD]), and quit ratios were calculated across survey years, and trends were examined within each race/ethnic group and comparing between CA and the United States, utilizing the 1992-2019 Tobacco Use Supplements to the Current Population Survey. Prevalence decreased for all race/ethnic groups. Current use among CA NHW showed significant decline compared with US counterparts, whereas US H/L showed greater decline than CA counterparts. CPD decreased by approximately 30% across race/ethnic groups, with CA groups having lower numbers. The greatest decrease occurred among AA in CA (average 10.3 CPD [95% confidence interval (CI): 10.3, 12.6] in 1992/1993 to 3 CPD [95% CI: 2.4, 3.7] in 2018/2019). Quit ratios increased from 1992/1993 to 2018/2019 for CA H/L 52.4% (95% CI: 49.8, 53.0) to 59.3 (95% CI: 55.8, 62.5) and CA NHWs 61.5% (95% CI: 60.7, 61.9) to 63.8% (95% CI: 63.9, 66.9). Although overall prevalence decreased over time for each racial/ethnic group, declines in CA outpaced the United States only for NHWs. Reductions in CPD were encouraging but the quit ratio points to the need to increase tobacco control efforts toward cessation. The successes in reduced cigarette use uptake and prevalence across time for both California and the rest of the United States were observed largely among non-Hispanic White populations. Although reductions in the number of cigarettes smoked per day are a notable success, particularly among the Californian African Americans, efforts to support quitting across racial/ethnic groups, especially marginalized groups, need to be prioritized.

Identifiants

pubmed: 33196799
pii: 5983615
doi: 10.1093/ntr/ntaa231
pmc: PMC8522466
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

909-919

Subventions

Organisme : NCI NIH HHS
ID : R01 CA234539
Pays : United States

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

MMWR Morb Mortal Wkly Rep. 2017 Dec 22;66(50):1374-1378
pubmed: 29267265
Nicotine Tob Res. 2015 Jun;17(6):755-9
pubmed: 25335947
Tob Control. 2020 Jan;29(Suppl 1):s5-s12
pubmed: 31992658
Tob Control. 2010 Apr;19 Suppl 1:i3-15
pubmed: 20382647
MMWR Morb Mortal Wkly Rep. 2018 Jan 19;67(2):53-59
pubmed: 29346338
MMWR Morb Mortal Wkly Rep. 2019 Nov 15;68(45):1013-1019
pubmed: 31725711
Ann Behav Med. 2004 Dec;28(3):152-7
pubmed: 15576252
Addiction. 2007 Oct;102 Suppl 2:5-29
pubmed: 17850611
MMWR Morb Mortal Wkly Rep. 2003 Aug 1;52(30):704-7
pubmed: 12894057
N Engl J Med. 2000 Dec 14;343(24):1772-7
pubmed: 11114317
Am J Prev Med. 2004 Feb;26(2):156-8
pubmed: 14751329
Tob Control. 2010 Apr;19 Suppl 1:i1-2
pubmed: 20382644
Tob Control. 2006 Aug;15(4):308-16
pubmed: 16885580
MMWR Morb Mortal Wkly Rep. 2018 Jan 26;67(3):97-102
pubmed: 29370150
Nicotine Tob Res. 2018 Aug 14;20(9):1085-1094
pubmed: 29059350
Prev Med. 2016 Oct;91:224-232
pubmed: 27575315
Tob Control. 2018 Oct;27(e2):e112-e117
pubmed: 29180534
JAMA. 2011 Mar 16;305(11):1106-12
pubmed: 21406647
Tob Control. 2007 Apr;16(2):91-5
pubmed: 17400945
Cancer Epidemiol Biomarkers Prev. 2010 Nov;19(11):2801-10
pubmed: 20852009
J Clin Oncol. 2018 Jan 1;36(1):25-33
pubmed: 29035642
Nicotine Tob Res. 2009 Feb;11(2):203-10
pubmed: 19246433
Am J Public Health. 2011 Apr;101(4):699-706
pubmed: 21330593
Cancer Prev Res (Phila). 2019 Jan;12(1):3-12
pubmed: 30305281
Health Educ Behav. 2015 Dec;42(6):742-51
pubmed: 25794519
N Engl J Med. 2006 Jan 26;354(4):333-42
pubmed: 16436765
Cancer Causes Control. 2009 Sep;20(7):1215-26
pubmed: 19609690
MMWR Morb Mortal Wkly Rep. 2018 Nov 09;67(44):1225-1232
pubmed: 30408019
Prev Med. 2019 Mar;120:144-149
pubmed: 30703378
J Natl Cancer Inst. 2008 Dec 3;100(23):1672-94
pubmed: 19033571

Auteurs

Kari-Lyn K Sakuma (KK)

Health Promotion and Health Behavior Program, School of Social and Behavioral Health Sciences, College of Public Health and Human Sciences, Oregon State University, Corvallis, OR.

John P Pierce (JP)

Department of Family Medicine and Public Health, Moores Cancer Center, University of California San Diego, La Jolla, CA.

Pebbles Fagan (P)

Fay W. Boozman College of Public Health, University of Arkansas for Medical Sciences, Little Rock, AR.

France T Nguyen-Grozavu (FT)

Department of Family Medicine and Public Health, Moores Cancer Center, University of California San Diego, La Jolla, CA.

Eric C Leas (EC)

Division of Health Policy, Department of Family Medicine and Public Health, University of California San Diego, La Jolla, CA.

Karen Messer (K)

Department of Family Medicine and Public Health, Moores Cancer Center, University of California San Diego, La Jolla, CA.

Martha M White (MM)

Department of Family Medicine and Public Health, Moores Cancer Center, University of California San Diego, La Jolla, CA.

Amanda S Tieu (AS)

Department of Family Medicine and Public Health, Moores Cancer Center, University of California San Diego, La Jolla, CA.

Dennis R Trinidad (DR)

Department of Family Medicine and Public Health, Moores Cancer Center, University of California San Diego, La Jolla, CA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH